Biblioteca Humberto Rosselli Quijano
Información del autor
Autor Robert S. Goodwin |
Documentos disponibles escritos por este autor (2)
Refinar búsquedaAntagonist elicited cannabis withdrawal in humans / David A Gorelick en Journal of Clinical Psychopharmacology, Año 2011 - Vol. 31 - No. 5 (Octubre)
Título : Antagonist elicited cannabis withdrawal in humans Tipo de documento: texto impreso Autores: David A Gorelick, Autor ; Robert S. Goodwin, Autor ; Eugene Schwilke, Autor Fecha de publicación: 2022 Artículo en la página: PP. 603-612 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Antagonista, Cannabis, Marihuana, Rimonabant, Abstinencia Resumen: Cannabinoid CB1 receptor antagonists have potential therapeutic benefits, but antagonist-elicited cannabis withdrawal has not been reported in humans. Ten male daily cannabis smokers received 8 days of increasingly frequent 20-mg oral Δ9-tetrahydrocannabinol (THC) dosages (40-120 mg/d) around-the-clock to standardize cannabis dependence while residing on a closed research unit. Link: ./index.php?lvl=notice_display&id=29356
in Journal of Clinical Psychopharmacology > Año 2011 - Vol. 31 - No. 5 (Octubre) . - PP. 603-612[artículo] Antagonist elicited cannabis withdrawal in humans [texto impreso] / David A Gorelick, Autor ; Robert S. Goodwin, Autor ; Eugene Schwilke, Autor . - 2022 . - PP. 603-612.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2011 - Vol. 31 - No. 5 (Octubre) . - PP. 603-612
Palabras clave: Antagonista, Cannabis, Marihuana, Rimonabant, Abstinencia Resumen: Cannabinoid CB1 receptor antagonists have potential therapeutic benefits, but antagonist-elicited cannabis withdrawal has not been reported in humans. Ten male daily cannabis smokers received 8 days of increasingly frequent 20-mg oral Δ9-tetrahydrocannabinol (THC) dosages (40-120 mg/d) around-the-clock to standardize cannabis dependence while residing on a closed research unit. Link: ./index.php?lvl=notice_display&id=29356
Título : Physiological and subjective responses to controlled oral 3,4-methylenedioxymethamphetamine administration Tipo de documento: texto impreso Autores: Erin A. Kolbrich, Autor ; Robert S. Goodwin, Autor ; David A Gorelick, Autor Fecha de publicación: 2023 Artículo en la página: pp. 432-440 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: MDMA, Dosificación controlada, Cardiovascular, Efectos subjetivos, Éxtasis Resumen: A randomized, within-subject, double blind, inpatient study of the physiological and subjective effects of oral 3,4-methylenedioxymethamphetamine (MDMA) was conducted in human volunteers with previous MDMA experience. Placebo, low (1.0 mg/kg), and high (1.6 mg/kg) doses of oral MDMA were administered in a controlled inpatient setting at least 7 days apart to six African-American (4 male, 2 female) and two Caucasian (both male) volunteers, mean (SE) age 21.1 (0.8) years and weight 77.2 (7.7) kg. MDMA doses were 46–150 mg, in the range of typical recreational doses. Link: ./index.php?lvl=notice_display&id=30844
in Journal of Clinical Psychopharmacology > Año 2008 - Vol. 28 - No. 4 (Agosto) . - pp. 432-440[artículo] Physiological and subjective responses to controlled oral 3,4-methylenedioxymethamphetamine administration [texto impreso] / Erin A. Kolbrich, Autor ; Robert S. Goodwin, Autor ; David A Gorelick, Autor . - 2023 . - pp. 432-440.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2008 - Vol. 28 - No. 4 (Agosto) . - pp. 432-440
Palabras clave: MDMA, Dosificación controlada, Cardiovascular, Efectos subjetivos, Éxtasis Resumen: A randomized, within-subject, double blind, inpatient study of the physiological and subjective effects of oral 3,4-methylenedioxymethamphetamine (MDMA) was conducted in human volunteers with previous MDMA experience. Placebo, low (1.0 mg/kg), and high (1.6 mg/kg) doses of oral MDMA were administered in a controlled inpatient setting at least 7 days apart to six African-American (4 male, 2 female) and two Caucasian (both male) volunteers, mean (SE) age 21.1 (0.8) years and weight 77.2 (7.7) kg. MDMA doses were 46–150 mg, in the range of typical recreational doses. Link: ./index.php?lvl=notice_display&id=30844
